New Releases from NCBI BookshelfNivolumab for adjuvant treatment of invasive urothelial cancer at high risk of recurrence.Nivolumab for adjuvant treatment of invasive urothelial cancer at high risk of recurrence.
Post Content
Uncategorized
New Releases from NCBI BookshelfComparing Two Medicines for Adults with Myasthenia Gravis – The PROMISE-MG Study [Internet].Comparing Two Medicines for Adults with Myasthenia Gravis – The PROMISE-MG Study [Internet].
Myasthenia gravis (MG) is an autoimmune neuromuscular disease caused by autoantibodies directed at the neuromuscular junction. The estimated prevalence is
